OP0291 ASSOCIATION OF BELIMUMAB USE WITH ORAL CORTICOSTEROID DOSE AND DISEASE ACTIVITY IN CHILDHOOD-ONSET LUPUS: OUTCOMES FROM A NESTED-CASE CONTROL ANALYSIS IN THE CHILDHOOD ARTHRITIS AND RHEUMATOLOGY RESEARCH ALLIANCE REGISTRY
Conferences
Roberts, J; Carlin, K; Hayward, K; Sadun, R; Smitherman, E; Wenderfer, S
Published in: Annals of the Rheumatic Diseases
June 2024
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Annals of the Rheumatic Diseases
DOI
ISSN
0003-4967
Publication Date
June 2024
Volume
83
Start / End Page
230 / 230
Publisher
Elsevier BV
Related Subject Headings
- Arthritis & Rheumatology
- 3204 Immunology
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Roberts, J., Carlin, K., Hayward, K., Sadun, R., Smitherman, E., & Wenderfer, S. (2024). OP0291 ASSOCIATION OF BELIMUMAB USE WITH ORAL CORTICOSTEROID DOSE AND DISEASE ACTIVITY IN CHILDHOOD-ONSET LUPUS: OUTCOMES FROM A NESTED-CASE CONTROL ANALYSIS IN THE CHILDHOOD ARTHRITIS AND RHEUMATOLOGY RESEARCH ALLIANCE REGISTRY. In Annals of the Rheumatic Diseases (Vol. 83, pp. 230–230). Elsevier BV. https://doi.org/10.1136/annrheumdis-2024-eular.4693
Roberts, J., K. Carlin, K. Hayward, R. Sadun, E. Smitherman, and S. Wenderfer. “OP0291 ASSOCIATION OF BELIMUMAB USE WITH ORAL CORTICOSTEROID DOSE AND DISEASE ACTIVITY IN CHILDHOOD-ONSET LUPUS: OUTCOMES FROM A NESTED-CASE CONTROL ANALYSIS IN THE CHILDHOOD ARTHRITIS AND RHEUMATOLOGY RESEARCH ALLIANCE REGISTRY.” In Annals of the Rheumatic Diseases, 83:230–230. Elsevier BV, 2024. https://doi.org/10.1136/annrheumdis-2024-eular.4693.
Roberts J, Carlin K, Hayward K, Sadun R, Smitherman E, Wenderfer S. OP0291 ASSOCIATION OF BELIMUMAB USE WITH ORAL CORTICOSTEROID DOSE AND DISEASE ACTIVITY IN CHILDHOOD-ONSET LUPUS: OUTCOMES FROM A NESTED-CASE CONTROL ANALYSIS IN THE CHILDHOOD ARTHRITIS AND RHEUMATOLOGY RESEARCH ALLIANCE REGISTRY. In: Annals of the Rheumatic Diseases. Elsevier BV; 2024. p. 230–230.
Roberts, J., et al. “OP0291 ASSOCIATION OF BELIMUMAB USE WITH ORAL CORTICOSTEROID DOSE AND DISEASE ACTIVITY IN CHILDHOOD-ONSET LUPUS: OUTCOMES FROM A NESTED-CASE CONTROL ANALYSIS IN THE CHILDHOOD ARTHRITIS AND RHEUMATOLOGY RESEARCH ALLIANCE REGISTRY.” Annals of the Rheumatic Diseases, vol. 83, Elsevier BV, 2024, pp. 230–230. Crossref, doi:10.1136/annrheumdis-2024-eular.4693.
Roberts J, Carlin K, Hayward K, Sadun R, Smitherman E, Wenderfer S. OP0291 ASSOCIATION OF BELIMUMAB USE WITH ORAL CORTICOSTEROID DOSE AND DISEASE ACTIVITY IN CHILDHOOD-ONSET LUPUS: OUTCOMES FROM A NESTED-CASE CONTROL ANALYSIS IN THE CHILDHOOD ARTHRITIS AND RHEUMATOLOGY RESEARCH ALLIANCE REGISTRY. Annals of the Rheumatic Diseases. Elsevier BV; 2024. p. 230–230.
Published In
Annals of the Rheumatic Diseases
DOI
ISSN
0003-4967
Publication Date
June 2024
Volume
83
Start / End Page
230 / 230
Publisher
Elsevier BV
Related Subject Headings
- Arthritis & Rheumatology
- 3204 Immunology
- 3202 Clinical sciences